1.Current Status of Dialysis Therapy in Korea.
The Korean Journal of Internal Medicine 2011;26(2):123-131
The number of patients with end-stage renal disease (ESRD) is rising very rapidly as the number of elderly and patients with diabetes increases in Korea. ESRD Registry Committee of the Korean Society of Nephrology (KSN) collected dialysis therapy data in Korea through an online registry program on the KSN website. The status of renal replacement therapy in Korea at the end of 2009 was as follows. First, total number of patients with ESRD was 56,396 (hemodialysis [HD], 37,391; peritoneal dialysis [PD], 7,618; functioning kidney transplant [KT], 11,387). The prevalence of ESRD was 1,113.6 patients per million population (PMP). Proportion of patients undergoing renal replacement therapy was 66.3% with HD, 13.5% with PD, and 20.2% with KT. Second, a total of 8,906 (HD, 6,540; PD, 1,125; KT, 1,241; incidence rate of 175.9 PMP) patients developed ESRD in 2009. Third, the most common primary causes of ESRD were diabetic nephropathy (45.4%), hypertensive nephrosclerosis (18.3%), and chronic glomerulonephritis (11.1%). Fourth, mean urea reduction rate was 67.5% and 73.8% in male and female patients, respectively, undergoing HD. Mean Kt/V was 1.38 in male patients and 1.65 in female patients. Fifth, the overall 5-year survival rate of male patients undergoing dialysis was 65.4% and that of female patients was 67.4%.
Adult
;
Aged
;
Anemia/drug therapy/etiology
;
Comorbidity
;
Erythropoietin, Recombinant/therapeutic use
;
Female
;
Hematinics/therapeutic use
;
Humans
;
Incidence
;
Kidney Failure, Chronic/mortality/*therapy
;
Male
;
Middle Aged
;
Prevalence
;
Registries
;
*Renal Dialysis/adverse effects/mortality
;
Republic of Korea/epidemiology
;
Risk Factors
;
Survival Rate
;
Time Factors
;
Treatment Outcome
2.Overlooked Management and Risk Factors for Anemia in Patients with Intestinal Behcet's Disease in Actual Clinical Practice.
Bun KIM ; Soo Jung PARK ; Sung Pil HONG ; Jae Hee CHEON ; Tae Il KIM ; Won Ho KIM
Gut and Liver 2015;9(6):750-755
BACKGROUND/AIMS: Anemia in patients with inflammatory bowel disease significantly affects the quality of life. The aim of this study was to investigate the frequency of and risk factors for anemia and to describe the management of anemia in patients with intestinal Behcet's disease (BD) in actual clinical practice. METHODS: We included 64 patients with intestinal BD who visited the outpatient clinic of a tertiary referral center in June 2011 and had available laboratory data for the subsequent 6 months. RESULTS: Anemia was detected in 26 patients (40.6%). After 6 months, anemia was still present in 14 of these patients (53.8%). The cause of anemia was investigated in eight patients (30.8%), and oral iron supplementation was prescribed to four patients (15.4%). Of these four patients, two (50%) recovered completely within 6 months. Anemia was associated with a high Disease Activity Index for Intestinal Behcet's Disease (DAIBD, p=0.024), erythrocyte sedimentation rate (p=0.003), and C-reactive protein (p=0.049) in univariate analysis. In multivariate analysis, the factor predictive for anemia in patients with intestinal BD was a higher DAIBD (> or =40; odds ratio, 4.08; 95% confidence interval, 1.21 to 13.71; p=0.023). CONCLUSIONS: Although anemia is common in intestinal BD patients, its clinical importance is overlooked in daily practice. Moderate to severe disease activity is predictive of anemia.
Adult
;
Anemia/drug therapy/epidemiology/*etiology
;
Behcet Syndrome/blood/*complications/pathology
;
Blood Sedimentation
;
C-Reactive Protein/analysis
;
Dietary Supplements
;
Disease Management
;
Female
;
Humans
;
Intestinal Diseases/blood/*complications/pathology
;
Iron/therapeutic use
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Odds Ratio
;
Predictive Value of Tests
;
Risk Factors
;
Severity of Illness Index
;
Trace Elements/therapeutic use